These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inhibiting the renin-angiotensin system: why and in which patients. Berra K; Miller NH J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897 [TBL] [Abstract][Full Text] [Related]
6. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system]. Boucek P Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602 [TBL] [Abstract][Full Text] [Related]
7. How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy? Kim ST; Park KH; Oh SC; Seo JH; Kim JS; Shin SW; Kim YH Oncology; 2012; 83(6):354-60. PubMed ID: 23052034 [TBL] [Abstract][Full Text] [Related]
8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
9. [The future of renin inhibition]. Uresin AY; Baran E Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475 [TBL] [Abstract][Full Text] [Related]
10. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. Verdecchia P; Gentile G; Angeli F; Reboldi G Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743 [TBL] [Abstract][Full Text] [Related]
11. [Renin inhibition and the kidney]. Ecder T Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474 [TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease. Kolesnyk I; Struijk DG; Dekker FW; Krediet RT Neth J Med; 2010 Jan; 68(1):15-23. PubMed ID: 20103817 [TBL] [Abstract][Full Text] [Related]
13. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders. Krum H; Gilbert RE J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168 [TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis. Tandon P; Abraldes JG; Berzigotti A; Garcia-Pagan JC; Bosch J J Hepatol; 2010 Aug; 53(2):273-82. PubMed ID: 20570385 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer. Yuge K; Miyajima A; Tanaka N; Shirotake S; Kosaka T; Kikuchi E; Oya M Ann Surg Oncol; 2012 Nov; 19(12):3987-93. PubMed ID: 22872290 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive drugs and fibrinolytic function. Fogari R; Zoppi A Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777 [TBL] [Abstract][Full Text] [Related]
17. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions. Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807 [TBL] [Abstract][Full Text] [Related]